20 March 2012
People could soon be subjected to a new type of brain scan in order to detect and treat tumours in this part of the human body.
Start-up company i2eye Diagnostics has developed the saccadic vector optokinetic perimetry, which uses vision to monitor brain tumours in children and vulnerable adults.
The innovative technology detects how a person naturally reacts to both movement and light by moving their head around a visual field, in an experiment which does not need a patient to give their own feedback.
By making use of a visual field, medical experts are able to establish any issues which a person is having with their central and peripheral vision, which could then be traced back to stroke or a brain tumour.
Peter Estibeiro, chief executive of i2eye Diagnostics, claimed: "Our instrument is a generation ahead of anything else currently on the market and has enormous potential."
According to Cancer Research UK, 4,785 people suffered from malignant brain and other CNS tumours in the UK during 2008 alone.
Posted by Jeanette Royston
Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.